Skip to main content

Population Health

By Jeff Lagasse | 04:31 pm | January 04, 2021
Carrimycin includes antiviral, anti-inflammatory and anti-fibrosis effects in addition to its antibacterial effect.
By Jeff Lagasse | 04:20 pm | December 31, 2020
Patients with severe allergies to foods, oral drugs, latex or venom can still safely receive the COVID-19 vaccines.
By Mallory Hackett | 02:45 pm | December 31, 2020
The state’s nursing homes have seen more than 10,000 COVID-19 cases and close to 2,000 deaths.   
By Jeff Lagasse | 01:33 pm | December 31, 2020
The findings give healthcare workers an insight into how patients may be affected, and could lead to more effective treatments.
By Jeff Lagasse | 12:18 pm | December 31, 2020
There were no safety issues found, and the side effects have been mild, although more research is needed on its effect on transmission.
By Kat Jercich | 11:56 am | December 31, 2020
Some of the hurdles around vaccine distribution could be addressed with high-tech solutions, particularly where environmental management is concerned.
SPONSORED
By Health Catalyst | HIMSS TV | 06:07 pm | December 30, 2020
When building predictive models that improve, not drive, health disparities, turn to augmented intelligence, not artificial intelligence, says Jason Jones, chief data scientist at Health Catalyst.
By Jeff Lagasse | 12:00 pm | December 30, 2020
Inequities were found by race/ethnicity, socioeconomic status, age, and when someone used a language other than English.
By Jeff Lagasse | 04:16 pm | December 29, 2020
Roughly 40% of Medicare beneficiaries plan to get a coronavirus vaccine, the highest percentage among all groups.
By Jeff Lagasse | 02:26 pm | December 29, 2020
The investigational vaccine is made from a stabilized form of the coronavirus spike protein using recombinant protein nanoparticle technology.